Diversified LLC Has $1.72 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Diversified LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,384 shares of the healthcare conglomerate’s stock after buying an additional 388 shares during the quarter. Diversified LLC’s holdings in UnitedHealth Group were worth $1,723,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Macroview Investment Management LLC increased its position in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 47 shares in the last quarter. Delos Wealth Advisors LLC grew its holdings in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after acquiring an additional 53 shares in the last quarter. True Wealth Design LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at approximately $31,000. Bbjs Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group during the second quarter worth $31,000. Finally, Signature Resources Capital Management LLC lifted its position in shares of UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 18 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have recently weighed in on UNH shares. Truist Financial upped their price target on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Argus raised their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Wells Fargo & Company raised their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Barclays raised their price target on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Finally, UBS Group lifted their target price on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. One research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $614.17.

UnitedHealth Group Price Performance

Shares of UNH traded up $5.79 during midday trading on Friday, hitting $584.51. 2,222,692 shares of the company traded hands, compared to its average volume of 4,165,972. The firm has a 50 day moving average of $537.83 and a 200-day moving average of $509.96. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $591.54. The stock has a market cap of $539.75 billion, a price-to-earnings ratio of 35.73, a PEG ratio of 1.61 and a beta of 0.59. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter last year, the firm earned $6.14 EPS. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. On average, analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.44%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Insider Transactions at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.